CIK 0001069899
- Large accelerated filer
PHIBRO ANIMAL HEALTH CORP
Sign in to watch- Ticker
- PAHC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 131840497
- Phone
- +1 201-329-7300
- Business address
- GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD., SUITE 21, TEANECK, NJ, 07666
- Former names
- PHILIPP BROTHERS CHEMICALS INC
- 4 Grant or award Exec. VP, Corporate Strategy acquired 3,964 shares (grant or award)
- 4 Grant or award President and CEO acquired 16,840 shares (grant or award)
- 4 Grant or award Escudero Lisa Ann acquired 2,152 shares (grant or award)
- 4 Grant or award Andolino Anthony acquired 1,793 shares (grant or award)
- 4 Open-market buy Director bought 5,000 shares at $22.10 ($110,500)
- 4 Exercise or conversion Chief Financial Officer acquired 30,000 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 5,000 shares at $20.02 ($100,100)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 5,000 shares at $23.68 ($118,400)
- 4 Open-market sale Chief Operating Officer sold 20,000 shares at $22.94 ($458,812)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 5,000 shares at $21.21 ($106,050)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Exec. VP, Corporate Strategy sold 9,780 shares at an average $31.34 ($306,478)
- 4 Open-market sale Exec. VP, Corporate Strategy sold 7,500 shares at an average $31.63 ($237,254)
Page 4 of 17 · 334 filings